Encompass Health logo

EHC - Encompass Health Share Price

$66.51 0.6  0.9%

Last Trade - 20/10/20

Large Cap
Market Cap £5.06bn
Enterprise Value £7.82bn
Revenue £3.55bn
Position in Universe 997th / 6432
Unlock EHC Revenue
Relative Strength (%)
1m -4.43%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -20.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
2,374 3,116 3,646 3,914 4,277 4,605 4,686 5,191 +14.2%
+10.7 -8.6 +19.8 +11.5 +18.2 +8.3 -21.1 +38.3
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Encompass Health Corp revenues remained flat at $2.26B. Net income applicable to common stockholders excluding extraordinary items decreased 38% to $120.2M. Revenues reflect homehealth & Hospice segment increase of 1% to $522.4M, Patient Days-Hospice increase of 35% to 671K, also reflect Inpatient and Other Clinical Services segment decrease of 1% to $1.73B.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for EHC
Graphical History


EHC Revenue Unlock EHC Revenue

Net Income

EHC Net Income Unlock EHC Revenue

Normalised EPS

EHC Normalised EPS Unlock EHC Revenue

PE Ratio Range

EHC PE Ratio Range Unlock EHC Revenue

Dividend Yield Range

EHC Dividend Yield Range Unlock EHC Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
EHC EPS Forecasts Unlock EHC Revenue
Profile Summary

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 36 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice. It is an owner and operator of inpatient rehabilitation hospitals. It provides specialized rehabilitative treatment on both an inpatient and outpatient basis. It offers its home health and hospice services through Encompass Home Health and Hospice business (Encompass). Encompass operates home health and hospice agencies in 30 states, with concentrations in the Southeast, Oklahoma, and Texas. As of December 31, 2018, the Company operated 130 inpatient rehabilitation hospitals.

Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated February 22, 1984
Public Since September 24, 1986
No. of Shareholders: 7,453
No. of Employees: 31,570
Sector Healthcare
Industry Healthcare Providers & Services
Index S&P 400 Mid Cap , S&P Composite 1500 ,
Exchange New York Stock Exchange
Shares in Issue 99,445,949
Free Float (0.0%)
Eligible for
EHC Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for EHC
Upcoming Events for EHC
Frequently Asked Questions for Encompass Health
What is the Encompass Health share price?

As of 20/10/20, shares in Encompass Health are trading at $66.51, giving the company a market capitalisation of £5.06bn. This share price information is delayed by 15 minutes.

How has the Encompass Health share price performed this year?

Shares in Encompass Health are currently trading at $66.51 and the price has moved by -1.27% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Encompass Health price has moved by -14.79% over the past year.

What are the analyst and broker recommendations for Encompass Health?

Of the analysts with advisory recommendations for Encompass Health, there are there are currently 5 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Encompass Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Encompass Health next release its financial results?

Encompass Health is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Encompass Health dividend yield?

The Encompass Health dividend yield is 1.7% based on the trailing twelve month period.

Does Encompass Health pay a dividend?

Last year, Encompass Health paid a total dividend of 1.12, and it currently has a trailing dividend yield of 1.7%. Looking ahead, Encompass Health has not announced an ex-dividend date yet.

When does Encompass Health next pay dividends?

Encompass Health has yet to annouce their ex-dividend date. The historic dividend yield on Encompass Health shares is currently 1.7%.

How do I buy Encompass Health shares?

To buy shares in Encompass Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Encompass Health?

Shares in Encompass Health are currently trading at $66.51, giving the company a market capitalisation of £5.06bn.

Where are Encompass Health shares listed? Where are Encompass Health shares listed?

Here are the trading details for Encompass Health:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: EHC
What kind of share is Encompass Health?

Based on an overall assessment of its quality, value and momentum, Encompass Health is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Encompass Health share price forecast 2020?

Shares in Encompass Health are currently priced at $66.51. At that level they are trading at 30.27% discount to the analyst consensus target price of 0.00.

Analysts covering Encompass Health currently have a consensus Earnings Per Share (EPS) forecast of 2.864 for the next financial year.

How can I tell whether the Encompass Health share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Encompass Health. Over the past six months, the relative strength of its shares against the market has been -21.84%. At the current price of $66.51, shares in Encompass Health are trading at -3.23% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Encompass Health PE Ratio?

The Encompass Health PE ratio based on its reported earnings over the past 12 months is 22.85. The shares are currently trading at $66.51.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Encompass Health?

Encompass Health's management team is headed by:

Leo Higdon - NEC
Mark Tarr - PRE
Yvonne Curl - IND
Donald Correll - IND
John Chidsey - IND
Edmund Fay - SVP
Andrew Price - CAO
Douglas Coltharp - CFO
April Anthony - CEX
Patrick Darby - EVP
Elissa Charbonneau - OTH
Barbara Jacobsmeyer - EVP
Anthony Hernandez - CHO
Gregory Carmichael - IND
Who are the major shareholders of Encompass Health?

Here are the top five shareholders of Encompass Health based on the size of their shareholding:

Wellington Management Company, LLP Investment Advisor/Hedge Fund
Percentage owned: 10.07% (10.0m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 9.75% (9.69m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 8.38% (8.33m shares)
William Blair Investment Management, LLC Investment Advisor/Hedge Fund
Percentage owned: 4.59% (4.56m shares)
Hartford MidCap Fund Mutual Fund
Percentage owned: 3.33% (3.31m shares)
Similar to EHC
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.